ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1961

Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study

Ketty Machado1, Diogo S Domiciano2, Luana G Machado3, Jaqueline B Lopes4, Camille P Figueiredo5, Valéria F. Caparbo3, Liliam Takayama3, Paulo Menezes6 and Rosa M R Pereira2, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division, Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 5Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 6Preventive medicine, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: adipose tissue, body mass, bone density and sarcopenia, Elderly

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Epidemiology and Public Health Poster III: Rheumatic Disease Risk and Outcomes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sarcopenia is a syndrome characterized by progressive loss of skeletal muscle mass, which results in decreased muscle strength and impairment of functional capacity. Moreover, sarcopenia is an important clinical problem in older people with some adverse outcomes including an increased risk of death. Despite the increasing frequency of this clinical condition, prospective data about risk factors for low muscle mass are scarce and few studies have performed a comprehensive evaluation of clinical data, laboratory bone parameters and bone mineral density (BMD) to determine more accurately the contribution of each of these variables to risk of low muscle mass in elderly persons. Moreover, the influence of the visceral fat assessed by DXA on low muscle mass is poorly studied. Thus, this study aimed to identify the main risk factors (clinical, laboratory parameters, BMD, body composition by DXA including visceral fat) for low muscle mass, in a longitudinal, prospective, population-based cohort of Brazilian older women.

Methods: A total of 408 women aged 65 years and older from the São Paulo Ageing & Health study (SPAH) was evaluated with clinical data, laboratory bone tests, BMD and body composition by DXA. All risk factors were performed at baseline (2005-2007). Along with the Foundation for the National Institutes of Health (FNIH) criteria, low muscle mass was defined when appendicular lean mass divided by body mass index (ALM/BMI) is less than 0.512 (value for female). After a mean follow-up of 4.3±0.8 years, subjects were classified according to the appendicular muscle mass obtained by DXA. Logistic regression models were used to identify independent risk factors for low muscle mass.

Results: 116 women (28.4%; 95% CI: 24.0-32.7) had low muscle mass at the end of follow-up. Age averages were 73.3±4.9 years and 72.5±4.5 years, in the low muscle mass group and in the normal muscle mass group, respectively (p=0.11). Mean BMI was 30.6±5.2 kg/m2 in low muscle mass group and 28.1±4.7 kg/m2 in normal group (p<0.001). In multivariate analyses, predictors of low muscle mass were: number of falls (OR = 1.14, 95% CI 1.02-1.27, p = 0.016), TSH levels (OR = 1.08, 95% CI 1.01-1.15, p = 0.018, per each 1 μUI/L-increase), serum creatinine (OR = 11.11, 95% CI 2.78-33.33, p < 0.001, per each 1 mg/dL-decrease) and visceral adipose tissue (VAT) mass (OR = 1.17, 95% CI 1.07-1.27, p < 0.001, per each 100g-increase).

Conclusion:

Falls, higher TSH, lower creatinine and higher VAT were risk factors for low muscle mass in community-dwelling older women. These results reinforced that visceral fat, which is associated with metabolic syndrome and chronic inflammation, is related to muscle mass consumption and fragility in elderly. Taken together, these findings support the notion that more attention should be paid to these factors in clinical practice, since they are potentially reversible with adequate therapeutic intervention.


Disclosure: K. Machado, None; D. S. Domiciano, None; L. G. Machado, None; J. B. Lopes, None; C. P. Figueiredo, None; V. F. Caparbo, None; L. Takayama, None; P. Menezes, None; R. M. R. Pereira, None.

To cite this abstract in AMA style:

Machado K, Domiciano DS, Machado LG, Lopes JB, Figueiredo CP, Caparbo VF, Takayama L, Menezes P, Pereira RMR. Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/risk-factors-for-low-muscle-mass-in-community-dwelling-older-women-a-population-based-prospective-cohort-study-in-brazil-the-sao-paulo-ageing-health-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-low-muscle-mass-in-community-dwelling-older-women-a-population-based-prospective-cohort-study-in-brazil-the-sao-paulo-ageing-health-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology